Giovanni Maga

Title: Giovanni Maga: Innovator in Antiproliferative Agents

Introduction

Giovanni Maga is a notable inventor based in Pavia, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as antiproliferative agents. With a total of 2 patents, his work has the potential to impact the treatment of various diseases.

Latest Patents

Maga's latest patents include innovative compounds that demonstrate DDX3 inhibitory activity. The first patent focuses on the use of DDX3 inhibitors as antiproliferative agents, detailing compounds of formula I or II and their pharmaceutical compositions. This invention aims to provide new therapeutic options for conditions characterized by hyperproliferation. The second patent involves 4-substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine. This compound is particularly relevant for the treatment of bone-related diseases and tumors, showcasing the versatility of his research.

Career Highlights

Throughout his career, Giovanni Maga has worked with esteemed institutions such as Azienda Ospedaliera Universitaria Senese and Università Degli Studi Di Siena. His experience in these organizations has allowed him to collaborate with other professionals in the field and contribute to groundbreaking research.

Collaborations

Maga has collaborated with notable colleagues, including Maurizio Botta and Annalaura Brai. These partnerships have enriched his research and expanded the scope of his inventions.

Conclusion

Giovanni Maga's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work on antiproliferative agents has the potential to lead to advancements in medical treatments.